Clinical Trial

PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

Study acronym: PDAC-PATHWAYS
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to refine and pilot test PDAC-PATHWAYS, a digital informational and supportive care app for patients who are initiating neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Status change: Not Yet Recruiting → Recruiting 2026-04-15
Trial Details
NCT Number NCT07047807
Lead Sponsor Massachusetts General Hospital
Collaborators: United States Department of Defense
Conditions PDAC - Pancreatic Ductal Adenocarcinoma
Enrollment 50 participants
Start Date 2025-10-06
Primary Completion 2027-05 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-29